Follow
Avaniyapuram Kannan Murugan, M.Phil., Ph.D.
Avaniyapuram Kannan Murugan, M.Phil., Ph.D.
Scientist, Dept. of Molecular Oncology, King Faisal Specialist Hospital & Research Centre, Riyadh
Verified email at kfshrc.edu.sa
Title
Cited by
Cited by
Year
BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence
M Xing, R Liu, X Liu, AK Murugan, G Zhu, MA Zeiger, S Pai, J Bishop
Journal of clinical oncology 32 (25), 2718, 2014
7532014
Highly prevalent TERT promoter mutations in aggressive thyroid cancers
X Liu, J Bishop, Y Shan, S Pai, D Liu, AK Murugan, H Sun, AK El-Naggar, ...
Endocrine-related cancer 20 (4), 603, 2013
6602013
mTOR: Role in cancer, metastasis and drug resistance
AK Murugan
Seminars in cancer biology 59, 92-111, 2019
3752019
TERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancer
X Liu, S Qu, R Liu, C Sheng, X Shi, G Zhu, AK Murugan, H Guan, H Yu, ...
The Journal of Clinical Endocrinology & Metabolism 99 (6), E1130-E1136, 2014
3462014
Anaplastic Thyroid Cancers Harbor Novel Oncogenic Mutations of the ALK Gene
AK Murugan, M Xing
Cancer research 71 (13), 4403-4411, 2011
2532011
Oncogenic mutations of the PIK3CA gene in head and neck squamous cell carcinomas
AK Murugan, NT Hong, Y Fukui, AK Munirajan, N Tsuchida
International journal of oncology 32 (1), 101-111, 2008
1672008
Identification and functional characterization of isocitrate dehydrogenase 1 (IDH1) mutations in thyroid cancer
AK Murugan, E Bojdani, M Xing
Biochemical and biophysical research communications 393 (3), 555-559, 2010
1542010
Ras oncogenes in oral cancer: the past 20 years
AK Murugan, AK Munirajan, N Tsuchida
Oral oncology 48 (5), 383-392, 2012
1342012
RAS mutations in human cancers: Roles in precision medicine
AK Murugan, M Grieco, N Tsuchida
Seminars in cancer biology 59, 23-35, 2019
1282019
Long noncoding RNAs: emerging players in thyroid cancer pathogenesis
AK Murugan, AK Munirajan, AS Alzahrani
Endocrine-related cancer 25 (2), R59-R82, 2018
1252018
APOBEC: A molecular driver in cervical cancer pathogenesis
S Revathidevi, AK Murugan, H Nakaoka, I Inoue, AK Munirajan
Cancer letters 496, 104-116, 2021
1102021
Histone deacetylation of NIS promoter underlies BRAF V600E-promoted NIS silencing in thyroid cancer
Z Zhang, D Liu, AK Murugan, Z Liu, M Xing
Endocrine-Related Cancer 21 (2), 161-173, 2014
1052014
Identification of RASAL1 as a Major Tumor Suppressor Gene in Thyroid Cancer
D Liu, C Yang, E Bojdani, AK Murugan, M Xing
Journal of the National Cancer Institute 105 (21), 1617-1627, 2013
1012013
MEK1 mutations, but not ERK2 mutations, occur in melanomas and colon carcinomas, but none in thyroid carcinomas
AK Murugan, J Dong, J Xie, M Xing
Cell cycle 8 (13), 2122-2124, 2009
952009
TERT Promoter Mutations in Thyroid Cancer
AS Alzahrani, R Alsaadi, AK Murugan, BB Sadiq
Hormones and Cancer 7, 165-177, 2016
932016
Genetic deregulation of the PIK3CA oncogene in oral cancer
AK Murugan, AK Munirajan, N Tsuchida
Cancer letters 338 (2), 193-203, 2013
772013
Kirsten Ras oncogene: significance of its discovery in human cancer research
N Tsuchida, AK Murugan, M Grieco
Oncotarget 7 (29), 46717, 2016
732016
Dysregulation of miR-200 family microRNAs and epithelial-mesenchymal transition markers in oral squamous cell carcinoma
G Arunkumar, AK Deva Magendhra Rao, M Manikandan, ...
Oncology letters 15 (1), 649-657, 2018
662018
Single point mutations in pediatric differentiated thyroid cancer
AS Alzahrani, AK Murugan, E Qasem, M Alswailem, H Al-Hindi, Y Shi
Thyroid 27 (2), 189-196, 2017
662017
LncRNA OIP5-AS1 is overexpressed in undifferentiated oral tumors and integrated analysis identifies as a downstream effector of stemness-associated …
G Arunkumar, S Anand, P Raksha, S Dhamodharan, ...
Scientific reports 8 (1), 7018, 2018
582018
The system can't perform the operation now. Try again later.
Articles 1–20